Cargando…
Treatment of Acute Delirium in a Patient with Parkinson’s Disease by Transfer to the Intensive Care Unit and Administration of Dexmedetomidine
The treatment of delirium or psychosis in patients with Parkinson’s disease (PD) can be complicated by the limited number of pharmacological agents that can be used in this population. Typical and atypical antipsychotics are contraindicated, as they can worsen motor symptoms. The treatment of acute...
Autores principales: | Lombardo, Morgan, DiPiazza, Amanda, Rippey, Kelly, Lubarr, Naomi, Clar, Elana, Azmi, Hooman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280942/ https://www.ncbi.nlm.nih.gov/pubmed/32498499 http://dx.doi.org/10.14802/jmd.20005 |
Ejemplares similares
-
Defining the Role of Dexmedetomidine in the Prevention of Delirium in the Intensive Care Unit
por: Nelson, S., et al.
Publicado: (2015) -
Dexmedetomidine and postoperative delirium: Decoding the evidence!
por: Magoon, Rohan, et al.
Publicado: (2020) -
Dexmedetomidine in Prevention of Postoperative Delirium: A Systematic Review
por: Fondeur, Jack, et al.
Publicado: (2022) -
Dexmedetomidine in prevention and treatment of postoperative and intensive care unit delirium: a systematic review and meta-analysis
por: Flükiger, Julian, et al.
Publicado: (2018) -
Additional sedative drugs to light sedation with dexmedetomidine is risk for delirium
por: Sakuraya, M, et al.
Publicado: (2015)